CAS: 1086062-66-9 - Omipalisib

Fórmula: C₂₅H₁₇F₂N₅O₃S

InChI: InChI=1S/C25H17F2N5O3S/c1-35-25-23(32-36(33,34)24-5-3-18(26)12-21(24)27)11-17(13-29-25)15-2-4-22-20(10-15)19(7-8-28-22)16-6-9-30-31-14-16/h2-14,32H,1H3

Chave InChI: InChIKey=CGBJSGAELGCMKE-UHFFFAOYSA-N

SMILES: O=S(=O)(NC=1C=C(C=NC1OC)C=2C=CC3=NC=CC(C=4C=NN=CC4)=C3C2)C5=CC=C(F)C=C5F

Sinónimos:

• 2,4-Difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide
• Benzenesulfonamide, 2,4-difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]-
• Gsk 2126458
• Gsk 458
• Gsk2126458

GSK-2126458

CAS: 1086062-66-9

• Fórmula: C₂₅H₁₇F₂N₅O₃S
• Pureza: 98%
• Cor e Forma: Solid
• Peso molecular: 505.4960

GSK2126458

CAS: 1086062-66-9

Omipalisib

CAS: 1086062-66-9

Omipalisib (GSK2126458) is a small-molecule pyridylsulfonamide inhibitor of phosphatidylinositol 3-kinase (PI3K) with potential antineoplastic activity.

• Fórmula: C₂₅H₁₇F₂N₅O₃S
• Pureza: 99.8%
• Cor e Forma: Solid
• Peso molecular: 505.5

GSK 2126458

CAS: 1086062-66-9

• Fórmula: C₂₅H₁₇F₂N₅O₃S
• Cor e Forma: Neat
• Peso molecular: 505.5

GSK 2126458

CAS: 1086062-66-9

PI3K enzyme inhibitor; antineoplastic

• Pureza: Min. 98 Area-%
• Cor e Forma: Powder